Cytokines as therapy for opportunistic fungal infections

Research in Immunology

Volumn 149, Issue 4-5, 1998, Pages 478-488

  Kullberg, B J ^a,c   Anaissie, E J ^b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BLOOD TRANSFUSION; CANDIDA ALBICANS; CELL KILLING; CELL MIGRATION; IMMUNOMODULATION; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MYCOSIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW;

EID: 0032078659     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(98)80771-2     Document Type: Article

References (133)

1. Aguirre, K., Havell, E.A., Gibson, G.W. & Johnson, L.L. (1995), Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun., 63, 1725-1731.
2. Aisner, J., Schiffer, C.A. & Wiernik, P.H. (1978), Granulocyte transfusions: evaluation of factors influencing results and a comparison of filtration and intermittent centrifugation leukapheresis. Br. J. Haematol., 38, 121-129.
3. Alavi, J.B., Root, R.K., Djerassi, I., Evans, A.E., Gluckman, S.J., MacGregor, R.R., Guerry, D., Schreiber, A.D., Shaw, J.M., Koch, P. & Cooper, R.A. (1977), A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N. Engl. J. Med., 296, 706-711.
4. Anaissie, E.J., Abi-Said, D., Uzun, O., Mera, J., Gentry, L.O., Williams, T., Kontoyiannis, D.P., Karl, C.L. & Bodey, G.P. (1996a), Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature. Clin. Infect. Dis., 23, 974-972.
5. Anaissie, E.J., Vartivarian, S., Bodey, G.P., Legrand, C., Kantarjian, H., Abi Said, D., Karl, C. & Vadhan Raj, S. (1996b), Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) in cancer patients with fever and neutropenia. Am. J. Med., 100, 17-23.
6. Andrews, A.T., Zmijewski, C.M., Bowman, H.S. & Reihart, J.K. (1976), Transfusion reaction with pulmonary infiltration associated with HL-A-specific leukocyte antibodies. Am. J. Clin. Pathol., 66, 483-487.
7. Antman, K.S., Griffin, J.D., Elias, A., Socinski, M.A., Ryan, L., Cannistra, S.A., Oette, D., Whitley, M., Frei, E.D. & Schnipper, L.E. (1988), Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N. Engl. J. Med., 319, 593-598.
8. Beaman, L. (1991), Effects of recombinant gamma interferon and tumor necrosis factor on in vitro interactions of human mononuclear phagocytes with Coccidioides immitis. Infect. Immun., 59, 4227-4229.
9. Bensinger, W.I., Price, T.H., Dale, D.C., Appelbaum, F.R., Clift, R., Lilleby, K., Williams, B., Storb, R., Thomas, E.D. & Buckner, C.D. (1993), The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood, 81, 1883-1888.
10. Biesma, B., de Vries, E.G., Willemse, P.M., Sluiter, W.J., Postmus, P.E., Limburg, P.C., Stern, A.C. & Vellenga, E. (1990), Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever. Eur. J. Cancer, 26, 932-936.
11. Billiau, A. (1996), Interferon-γ: biology and role in pathogesis. Adv. Immunol., 61, 61-130.
12. Blasi, E., Pitzurra, L., Bartoli, A., Puliti, M. & Bistoni, F. (1994), Tumor necrosis factor as an autocrine and paracrine signal controlling the macrophage secretory response to Candida albicans. Infect. Immun., 62, 1199-1206.
13. Bodey, G.P. (1984), Candidiasis in cancer patients. Am. J. Med., 77(4D), 13-19.
14. Bodey, G.P., Anaissie, E., Gutterman, J. & Vadhan-Raj, S. (1993), Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer. Clin. Infect. Dis., 17, 705-707.
15. Brummer, E., Hanson, L.H., Restrepo, A. & Stevens, D.A. (1988), In vivo and in vitro activation of pulmonary macrophages by IFN-γ for enhanced killing of Paracoccidioides brasiliensis or Blastomyces dermatitidis. J. Immunol., 140, 2786-2789.
16. Brummer, E., Morrison, C.J. & Stevens, D.A. (1985), Recombinant and natural gamma-interferon activation of macrophages in vitro: different dosage requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi. Infect. Immun., 49, 724-730.
17. Brummer, E. & Stevens, D.A. (1994), Macrophage colony-stimulating factor induction of enhanced macrophage anticryptococcal activity : synergy with fluconazole for killing. J. Infect. Dis., 170, 173-179.
18. Cenci, E., Bartocci, A., Puccetti, P., Mocci, S., Stanley, E.R. & Bistoni, F. (1991), Macrophage colony-stimulating factor in murine candidiasis-serum and tissue levels during infection and protective effect of exogenous administration. Infect. Immun., 59, 868-872.
19. Cenci, E., Perito, S., Enssle, K.H., Mosci, P., Latge, J.P., Romani, L. & Bistoni, F. (1997), Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect. Immun., 65, 564-570.
20. Chipping, P.M., Lloyd, E. & Goldman, J.M. (1980), Haemolysis after granulocyte transfusions. Br. Med. J., 281, 1529.
21. demons, K.V., Brummer, E. & Stevens, D.A. (1994), Cytokine treatment in central nervous system infecton: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob. Agents Chemother., 38, 460-464.
22. Cohen, D., Weinstein, H., Mihm, M. & Yankee, R. (1979), Nonfatal graft-versus-host disease occurring after transfusion with leukocytes and platelets obtained from normal donors. Blood, 53, 1053-1057.
23. Collins, H.L. & Bancroft, G.J. (1992), Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-α and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur. J. Immunol., 22, 1447-1454.
24. Crawford, J., Ozer, H., Stoller, R., Johnson, D., Lyman, G., Tabbara, I., Kris, M., Grous, J., Picozzi, V., Rausch, G. & et al. (1991), Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N. Engl. J. Med., 325, 164-170.
25. Cummings, N.P., Papbst, M.J. & Johnston, R.B., Jr. (1980), Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide. J. Exp. Med., 152, 1659-1669.
26. Dana, B.W., Durie, B.G., White, R.F. & Huestis, D.W. (1981), Concomitant administration of granulocyte transfusions and amphotericin B in neutropenic patients: absence of significant pulmonary toxicity. Blood, 57, 90-94.
27. DeGregorio, M.W., Lee, M.W. & Ries, C.A. (1981), Pulmonary reactions associated with amphotericin B and leukocyte transfusions. N. Engl. J. Med., 305, 585.
28. Denning, D.W. (1996), Therapeutic outcome in invasive aspergillosis. Clin. Infect. Dis., 23, 608-615.
29. Diamond, R.D. & Krzesicki, R. (1978), Mechanisms of attachment of neutrophils to Candida albicans pseudohyphae in the absence of serum, and subsequent damage to pseudohyphae by microbicidal processes of neutrophils in vitro. J. Clin. Invest., 61, 360-369.
30. Diamond, R.D., Krzesicki, R., Epstein, B. & Jao, W. (1978), Damage to hyphal forms of fungi by human leukocytes in vitro: a possible host defense mechanism in aspergillosis and mucormycosis. Am. J. Pathol., 91, 313-328.
31. Diamond, R.D., Lyman, C.A. & Wysong, D.R. (1991), Disparate effects of interferon-γ and tumor necrosis factor-α on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro. J. Clin. Invest., 87, 711-720.
32. Dignani, M.C., Anaissie, E.J., Hester, J.P., O'Brien, S., Vartivarian, S.E., Rex, J.H., Kantarjian, H., Jendiroba, D.B., Lichtiger, B., Andersson, B.S. & Freireich, E.J. (1997), Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia, 11, 1621-1630.
33. Djeu, J.Y., Blanchard, D.K., Halkias, D. & Friedman, H. (1986), Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-γ and tumor necrosis factor. J. Immunol., 137, 2980-2984.
34. Dutcher, J.P., Kendall, J., Norris, D., Schiffer, C., Aisner, J. & Wiernik, P.H. (1989), Granulocyte transfusion therapy and amphotericin B: adverse reactions? Am. J. Hematol., 31, 102-108.
35. Ezekowitz, R.A.B., Sieff, C.A., Dinauer, M.C., Nathan, D.G., Orkin, S.H. & Newburger, P.E. (1990), Restoration of phagocyte function by interferon-γ in X-linked chronic granulomatous disease occurs at the level of a progenitor cell. Blood, 76, 2443-2448.
36. Feldman, E., Hester, J.P. & Vartivarian, S.E. (1993), The use of granulocyte colony-stimulating factor-enhanced granulocyte transfusions from normal donors in patients with neutropenia-related fungal infections, in "33rd Interscience Conference on Antimicrobial Agents and Chemotherapy". New Orleans, LA.
37. Filler, S.G., Pfunder, A.S., Spellberg, B.J., Spellberg, J.P. & Edwards, J.E., Jr. (1996), Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells. Infect. Immun., 64, 2609-2617.
38. Ford, J.M., Brown, L.M., Cullen, M.H., Oliver, R.T., Wadsworth, J. & Lister, T.A. (1982), Combined granulocyte and platelet transfusions. Development of alloimmunization as reflected by decreasing cell recovery values. Transfusion, 22, 498-503.
39. Fortuny, I.E., Bloomfield, C.D., Hadlock, D.C., Goldman, A., Kennedy, B.J. & McCullough, J.J. (1975), Granulocyte transfusion: a controlled study in patients with acute nonlymphocytic leukemia. Transfusion, 15, 548-558.
40. Freireich, E.J., Levin, R.H. & Wang, J. (1964), The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic patients. Ann. N.Y. Acad. Sci., 113, 1081-1089.
41. Gallin, J.I., Malech, H.L., Melnick, D.A. & and the international chronic granulomatous disease cooperative study group (1991), A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N. Engl. J. Med., 324, 509-516.
42. Gerhartz, H.H., Engelhard, M., Meusers, P., Brittinger, G., Wilmanns, W., Schlimok, G., Mueller, P., Huhn, D., Musch, R., Siegert, W. & et al. (1993), Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas. Blood, 82, 2329-2339.
43. Gonzalez, C.E., Couriel, D.R. & Walsh, T.J. (1997), Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor. Clin. Infect. Dis., 24, 192-196.
44. Granger, D.L., Hibbs, J.B., Jr., Perfect, J.R. & Durack, D.T. (1988), Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J. Clin. Invest., 81, 1129-1136.
45. Grauer, M.E., Bokemeyer, C., Bautsch, W., Freund, M. & Link, H. (1994), Successful treatment of a Trichosporon beigelii septicemia in a granulocytopenic patient with amphotericin B and granulocyte colony-stimulating factor. Infection, 22, 283-286.
46. Graw, R.G., Jr., Herzig, G., Perry, S. & Henderson, E.S. (1972), Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. N. Engl. J. Med., 287, 367-371.
47. Graybill, J.R., Bocanegra, R. & Luther, M. (1995), Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis. Eur. J. Clin. Microbiol. Infect. Dis., 14, 700-703.
48. Hennequin, C., Benkerrou, M., Gaillard, J.L., Blanche, S. & Fraitag, S. (1994), Role of granulocyte colony-stimulating factor in the management of infection with Fusarium oxysporum in a neutropenic child. Clin. Infect. Dis., 18, 490-491.
49. Herbrecht, R., Waller, J., Koenig, H., Morier, P. & Letscher, V. (1996), Synergistic efficacy of recombinant human granulocyte colony-stimulating factor and amphotericin B against disseminated candidosis in non neutropenic mice. J. Mycol. Med., 6, 43-48.
50. Hersman, J., Meyers, J.D., Thomas, E.D., Buckner, C.D. & Clift, R. (1982), The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann. Intern. Med., 96, 149-152.
51. Herzig, R.H., Herzig, G.P., Graw, R.G., Jr., Bull, M.I. & Ray, K.K. (1977), Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study. N. Engl. J. Med., 296, 701-705.
52. Higby, D.J., Freeman, A., Henderson, E.S., Sinks, L. & Cohen, E. (1976), Granulocyte transfusions in children using filter-collected cells. Cancer, 38, 1407-1413.
53. Higby, D.J., Mishler, J.M., Rhomberg, W., Nicora, R.W. & Holland, J.F. (1975a), The effect of a single or double dose of dexamethasone on granulocyte collection with the continuous flow centrifuge. Vox Sang, 28, 243-248.
54. Higby, D.J., Yates, J.W., Henderson, E.S. & Holland, J.F. (1975b), Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N. Engl. J. Med., 292, 761-766.
55. Hume, D.A. & Denkins, Y. (1992), The deleterious effect of macrophage colony-stimulating factor (CSF-1) on the pathology of experimental candidiasis in mice. Lymphokine Cytokine Res., 11, 95-98.
56. Ibrahim, A.S., Filler, S.G., Ghannoum, M.A. & Edwards, J.E., Jr. (1993), Interferon-γ protects endothelial cells from damage by Candida albicans. J. Infect. Dis., 167, 1467-1470.
57. Jeremias, J., Kalo-Klein, A. & Witkin, S.S. (1991), Individual differences in tumour necrosis factor and interleukin-1 production induced by viable and heat-killed Candida albicans. J. Med. Vet. Mycol., 29, 157-163.
58. Joly, V., Saint-Julien, L., Carbon, C. & Yeni, P. (1994), In vivo activity of interferon-γ in combination with amphotericin B in the treatment of experimental cryptococcosis. J. Infect. Dis., 170, 1331-1334.
59. Karbassi, A., Backer, J.M., Foster, J.S. & Moore, R.N. (1987), Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: evidence for augmented expression of mannose receptors. J. Immunol., 139, 417-421.
60. Karp, D.D., Ervin, T.J., Tuttle, S., Gorgone, B.C., Lavin, P. & Yunis, E.J. (1982), Pulmonary complications during granulocyte transfusions : incidence and clinical features. Vox Sang, 42, 57-61.
61. Khwaja, A., Johnson, B., Addison, I.E., Yong, K., Ruthen, K., Abramson, S. & Linch, D.C. (1991), In vivo effects on macrophage colony-stimulating factor on human monocyte function. Br. J. Haematol., 77, 25-31.
62. Kullberg, B.J., Netea, M.G., Curfs, J.H.A.J., Keuter, M., Meis, J.F.G.M. & Van der Meer, J.W.M. (1998), Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in non-neutropenic mice. J. Infect. Dis., 177, 175-181.
63. Kullberg, B.J. & Van 't Wout, J.W. (1994), Cytokines in the treatment of fungal infections. Biotherapy, 7, 195-210.
64. Kullberg, B.J., Van 't Wout, J.W., Hoogstraten, C. & Van Furth, R. (1993), Recombinant interferon-γ enhances resistance to acute disseminated Candida albicans infection in mice. J. Infect. Dis., 168, 436-443.
65. Kullberg, B.J., Van 't Wout, J.W., Poell, R.J.M. & Van Furth, R. (1992), Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in mice. Antimicrob. Agents Chemother., 36, 1225-1229.
66. Kullberg, B.J., Van 't Wout, J.W. & Van Furth, R. (1990), Role of granulocytes in enhanced host resistance to Candida albicans induced by recombinant interleukin-1. Infect. Immun., 58, 3319-3324.
67. Kullberg, B.J., Van 't Wout, J.W. & Van Furth, R. (1991), No effect of recombinant human interleukin-1 on the numbers of peripheral blood and peritoneal leukocytes during an acute inflammation. Inflammation, 15, 457-470.
68. Langermans, J.A.M., Van der Hulst, M.E.B., Nibbering, P.H., Hiemstra, P.S., Fransen, L. & Van Furth, R. (1992), IFN-γ-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α. J. Immunol., 148, 568-574.
69. Lehrer, R.I., Szklarek, D., Ganz, T. & Selsted, M.E. (1988), Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J. Clin. Invest., 81, 1829-1835.
70. Levitz, S.M. (1991), Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans. Infect. Immun., 59, 3393-3397.
71. Levitz, S.M. & Farrell, T.P. (1990), Human neutrophil degranulation stimulated by Aspergillus fumigatus. J. Leukocyte Biol., 46, 170-175.
72. Levitz, S.M. & Ferrell, T.P. (1990), Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines. Infect. Immun., 58, 1201-1209.
73. Levitz, S.M. & North, E.A. (1996), Gamma interferon gene expression and release in human lymphocytes directly activated by Cryptococcus neoformans and Candida albicans. Infect. Immun., 64, 1595-1599.
74. Levitz, S.M., Tabuni, A., Kornfeld, H., Reardon, C.C. & Golenbock, D.T. (1994), Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect. Immun., 62, 1975-1981.
75. Levitz, S.M., Tabuni, A., Nong, S.H. & Golenbock, D.T. (1996), Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide. Infect. Immun., 64, 945-951.
76. Liles, W.C., Huang, J.E., van Burik, J.A., Bowden, R.A. & Dale, D.C. (1997), Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J. Infect. Dis., 175, 1012-1015.
77. Louie, A., Baltch, A.L., Smith, R.P., Franke, M.A., Ritz, W.J., Singh, J.K. & Gordon, M.A. (1994), Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis. Infect. Immun., 62, 2761-2772.
78. Maertens, J., Demuynck, H., Verhoef, G., Vendenberghe, P., Zachée, P. & Boogaerts, M. (1997). Granulocyte-macrophage colony-stimulating factor (GM-CSF) fails to improve outcome in invasive fungal infections in neutropenic cancer patients, in "13th Congress of the International Society for Human and Animal Mycology", Parma (abstract P560).
79. Maher, D.W., Lieschke, G.J., Green, M., Bishop, J., Stuart Harris, R., Wolf, M., Sheridan, W.P., Kefford, R.F., Cebon, J., Olver, I. & et al. (1994), Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Ann. Intern. Med., 121, 492-501.
80. Mencacci, A., Cenci, E., Spaccapelo, R., Tonnetti, L., Romani, L., Puccetti, P. & Bistoni, F. (1995), Rationale for cytokine and anti-cytokine therapy of Candida albicans infection. J. Mycol. Med., 5, 25-30.
81. Murphy, J. W. (1993), Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response. Infect. Immun., 61, 4750-4759.
82. Nagai, H., Guo, J., Choi, H. & Kurup, V. (1995), Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis. J. Infect. Dis., 172, 1554-1560.
83. Natarajan, U., Brummer, E. & Stevens, D.A. (1997), Effect of granulocyte colony-stimulating factor on the candidacidal activity of polymorphonuclear neutrophils and their collaboration with fluconazole. Antimicrob. Agents Chemother., 41, 1575-1578.
84. Nemunaitis, J., Meyers, J.D., Buckner, C.D., Shannon-dorcy, K., Mori, M., Shulman, H., Bianco, J.A., Higano, C.S., Groves, E., Storb, R., Hansen, J., Appelbaum, F.R. & Singer, J.W. (1991), Phase-I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood, 78, 907-913.
85. Nemunaitis, J., Shannon-Dorcy, K., Appelbaum, F.R., Meyers, J., Owens, A., Day, R., Ando, D., O'Neill, C., Buckner, D. & Singer, J. (1993), Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood, 82, 1422-1427.
86. Netea, M.G., Blok, W.L., Kuliberg, B.J., Bemelmans, M., Vogels, M.T.E., Buurman, W.A. & Van der Meer, J.W.M. (1995), Pharmacological inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live micro-organisms in mice. J. Infect. Dis., 171, 393-399.
87. Perfect, J.R., Granger, D.L. & Durack, D.T. (1987), Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells. J. Infect. Dis., 156, 316-323.
88. Pettengell, R., Gurney, H., Radford, J.A., Deakin, D.P., James, R., Wilkinson, P.M., Kane, K., Bentley, J. & Crowther, D. (1992), Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood, 80, 1430-1436.
89. Phillips, P., Forbes, J.C. & Speert, D.P. (1991), Disseminated infection with Pseudallescheria boydii in a patient with chronic granulomatous disease: response to gamma-interferon plus antifungal chemotherapy. Pediatr. Infect. Dis. J., 10, 536-539.
90. Polak-Wyss, A. (1991), Protective effect of human granulocyte colony-stimulating factor (hG-CSF) on Cryptococcus and Aspergillus infections in normal and immunosuppressed mice. Mycoses, 34, 205-215.
91. Poynton, C.H., Barnes, R.A. & Rees, J. (1998), Interferon γ and granulocyte-macrophage colony-stimulating factor for the treatment of hepatosplenic candidosis in patients with acute leukemia. Clin. Infect. Dis., 26, 239-240.
92. Puccetti, P., Mencacci, A., Cenci, E., Spaccapelo, R., Mosci, P., Enssle, K.H., Romani, L. & Bistoni, F. (1994), Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. J. Infect. Dis., 169, 1325-1331.
93. Rex, J.H., Bennett, J.E., Gallin, J.I., Malech, H.L., Decarlo, E.S. & Melnick, D.A. (1991), In vivo interferon-γ therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. J. Infect. Dis., 163, 849-852.
94. Roilides, E., Holmes, A., Blake, C., Pizzo, P.A. & Walsh, T.J. (1995), Effects of granulocyte colony-stimulating factor and interferon-γ on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species. J. Leukoc. Biol., 57, 651-656.
95. Roilides, E., Holmes, A., Blake, C., Venzon, D., Pizzo, P.A. & Walsh, T.J. (1994), Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-γ. J. Infect. Dis., 170, 894-899.
96. Roilides, E., Uhlig, K., Venzon, D., Pizzo, P.A. & Walsh, T.J. (1993a), Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect. Immun., 61, 1185-1193.
97. Roilides, E., Uhlig, K., Venzon, D., Pizzo, P.A. & Walsh, T.J. (1993b), Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect. Immun., 61, 4870-4877.
98. Romani, L., Bistoni, F., Mencacci, A., Cenci, E., Spaccapelo, R. & Puccetti, P. (1995), IL12 in Candida albicans infections. Res. Immunol., 146, 532-538.
99. Romani, L., Mencacci, A., Cenci, E., Del Sero, G., Bistoni, F. & Puccetti, P. (1997a), An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. J. Immunol., 158, 2356-2362.
100. Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Del Sero, G., Nicoletti, I., Trinchieri, G., Bistoni, F. & Puccetti, P. (1997b), Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J. Immunol., 158, 5349-5356.
101. Romani, L., Mencacci, A., Grohmann, U., Mocci, S., Mosci, P., Puccetti, P. & Bistoni, F. (1992), Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J. Exp. Med., 176, 19-25.
102. Romani, L., Mencacci, A., Tonnetti, L., Spaccapelo, R., Cenci, E., Puccetti, P., Wolf, S.F. & Bistoni, F. (1994a), IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol., 153, 5167-5175.
103. Romani, L., Puccetti, P., Mencacci, A., Cenci, E., Spaccapelo, R., Tonnetti, L., Grohmann, U. & Bistoni, F. (1994b), Neutralization of IL-10 upregulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J. Immunol., 152, 3514-3521.
104. Roseff, S.A. & Levitz, S.M. (1993), Effect of endothelial cells on phagocyte-mediated anticryptococcal activity. Infect. Immun., 61, 3818-3824.
105. Rotrosen, D., Edwards, J.E., Jr., Gibson, T.R., Moore, J.C., Cohen, A.H. & Green, I. (1985), Adherence of Candida to cultured vascular endothelial cells: mechanism of attachment and endothelial cell penetration. J. Infect. Dis., 152, 1264-1273.
106. Rowe, J.M., Andersen, J.W., Mazza, J.J., Bennett, J.M., Paietta, E., Hayes, F.A., Oette, D., Cassileth, P.A., Stadtmauer, E.A. & Wiernik, P.H. (1995), A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (>55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490). Blood, 86, 457-462.
107. Rowe, J.M., Rubin, A. & Mazza, J.J. (1996), Incidence of infections in adult patients (>55) with acute myelogenous leukemia treated with yeast-derivced GM-CSF (sargramostim): results of a double blind prospective study by the Eastern Cooperative Oncology Group, in "Acute leukemias V: prognostic factors and treatment results" (W. Hiddemann and T. Büchner) (pp. 178). New York, NY, Springer Verlag.
108. Saag, M.S., Powderly, W.G., Cloud, G.A., Robinsin, P., Grieco, M.H., Sharkey, P.K., Thompson, S.E., Sugar, A.M., Tuazon, C.U., Fisher, J.F., Hyslop, N., Jacobson, J.M., Hafner, R. & Dismukes, W.E. (1992), Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N. Engl. J. Med., 326, 83-89.
109. Schiffer, C.A., Aisner, J., Daly, P.A., Schimpff, S.C. & Wiernik, P.H. (1979), Alloimmunization following prophylactic granulocyte transfusion. Blood, 54, 766-774.
110. Spaccapelo, R., Romani, L., Tonnetti, L., Cenci, E., Mencacci, A., Del Sero, G., Tognellini, R., Reed, S.G., Puccetti, P. & Bistoni, F. (1995), TGFβ is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. J. Immunol., 155, 1349-1360.
111. Spielberger, R.T., Falleroni, M.J., Coene, A.J. & Larson, R.A. (1993), Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient. Clin. Infect. Dis., 16, 528-530.
112. Steinbeck, M.A. & Roth, J.A. (1989), Neutrophil activation by recombinant cytokines. Rev. Infect. Dis., 11, 549-568.
113. Steinshamn, S. & Waage, A. (1992), Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect. Immun., 60, 4003-4008.
114. Tansho, S., Abe, S. & Yamaguchi, H. (1994), Inhibition of Candida albicans growth by murine peritoneal neutrophils and augmentation of the inhibitory activity by bacterial lipopolysaccharide. Microbiol. Immunol., 38, 379-383.
115. Uchida, K., Yamamoto, Y., Klein, T.W., Friedman, H. & Yamaguchi, H. (1992), Granulocyte-colony stimulating factor facilitates the restoration of resistance to opportunistic fungi in leukopenic mice. J. Med. Vet. Mycol., 30, 293-300.
116. Uzun, O. & Anaissie, E.J. (1996), Problems and controversies in the management of hematogenous candidiasis. Clin. Infect. Dis., 22 (Suppl. 2), S73-S88.
117. Van 't Wout, J.W., Poell, R. & Van Furth, R. (1992), The role of BCG-PPD-activated macrophages in resistance against systemic candidiasis in mice. Scand. J. Immunol., 36, 713-719.
118. Vazquez-Torres, A., Jones-Carson, J., Warner, T. & Balish, E. (1995), Nitric oxide enhances resistance of SCID mice to mucosal candidiasis. J. Infect. Dis., 172, 192-198.
119. Vecchiarelli, A., Cenci, E., Puliti, M., Blasi, E., Puccetti, P., Cassone, A. & Bistoni, F. (1989a), Protective immunity induced by low-virulence Candida albicans: cytokine production in the development of the anti-infectious state. Cell. Immunol., 124, 334-344.
120. Vecchiarelli, A., Monari, C., Baldelli, F., Pietrella, D., Retini, C., Tascini, C., Francisci, D. & Bistoni, F. (1995), Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS. J. Infect. Dis., 171, 1448-1454.
121. Vecchiarelli, A., Todisco, T., Puliti, M., Dottorini, M. & Bistoni, F. (1989b), Modulation of anti-Candida activity of human alveolar macrophages by interferon-gamma or interleukin-1 -alpha. Am. J. Respir. Cell. Mol. Biol., 1, 49-55.
122. Vitt, C.R., Fidler, J.M., Ando, D., Zimmerman, R.J. & Aukerman, S.L. (1994), Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic candidiasis in the rat. J. Infect. Dis., 169, 369-374.
123. Vogels, M.T.E., Mensink, E.J.B.M., Ye, K., Boerman, O.C., Verschuren, C.M.M., Dinarello, C. A. & Van der Meer, J.W.M. (1994), Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection. J. Immunol., 153, 5772-5780.
124. Vogels, M.T.E. & Van der Meer, J.W.M. (1992), Use of immune modulators in nonspecific therapy of bacterial infections. Antimicrob. Agents Chemother., 36, 1-5.
125. Vogler, W.R. & Winton, E.F. (1977), A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am. J. Med., 63, 548-555.
126. Ward, H.N. (1970), Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann. Intern. Med., 73, 689-694.
127. Weiden, P.L., Zuckerman, N., Hansen, J.A., Sale, G.E., Remlinger, K., Beck, T.M. & Buckner, C.D. (1981), Fatal graft-versus-host disease in a patient with lymphoblastic leukemia following normal granulocyte transfusion. Blood, 57, 328-332.
128. Williamson, P.R., Kwon Chung, K.J. & Gallin, J.I. (1992), Successful treatment of Paecilomyces varioti infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections. Clin. Infect. Dis., 14, 1023-1026.
129. Winston, D.J., Ho, W.G. & Gale, R.P. (1982), Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann. Intern. Med., 91, 509-515.
130. Winston, D.J., Ho, W.G., Howell, C.L., Miller, M.J., Mickey, R., Martin, W.J., Lin, C.H. & Gale, R.P. (1980), Cytomegalovirus infections associated with leukocyte transfusions. Ann. Intern. Med., 93, 671-675.
131. Wright, D.G., Robichaud, K.J., Pizzo, P.A. & Deisseroth, A.B. (1981), Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N. Engl. J. Med., 304, 1185-1189.
132. Wu-Hsieh, B.A. & Howard, D.H. (1992), Intracellular growth inhibition of Histoplasma capsulatum induced in murine macrophages by recombinant gamma interferon is not due to a limitation of the supply of methionine or cysteine to the fungus. Infect. Immun., 60, 698-700.
133. Yamamoto, Y., Klein, T.W., Friedman, H., Kimura, S. & Yamaguchi, H. (1993), Granulocyte colony-stimulating factor potentiates anti-Candida albicans growth inhibitory activity of polymorphonuclear cells. FEMS Immunol. Med. Microbiol., 7, 15-22.